What is not useful for diagnosis of myasthenia gravis?
**Question:** What is not useful for diagnosis of myasthenia gravis?
**Core Concept:** Myasthenia gravis (MG) is a neuromuscular disorder characterized by muscle weakness and fatigue due to the dysfunction of the neuromuscular junction. Diagnosis involves a combination of clinical evaluation, electromyography (EMG), and laboratory tests like acetylcholine receptor (AChR) antibodies.
**Why the Correct Answer is Right:** The correct answer is **D.** Acetylcholine (Ach) level in blood is not useful for diagnosis of myasthenia gravis. Although Ach is a key neurotransmitter involved in neuromuscular transmission, measuring its blood levels does not provide direct information about the neuromuscular junction dysfunction seen in myasthenia gravis.
**Why Each Wrong Option is Incorrect:**
A. **Acetylcholinesterase (AChE) level:** AChE is an enzyme responsible for breaking down Ach at the neuromuscular junction. Measuring AChE levels in blood does not directly reflect neuromuscular junction dysfunction in MG.
B. **Muscle strength test:** Assessing muscle strength is an important part of the clinical evaluation in myasthenia gravis diagnosis. However, it is not a definitive test for MG diagnosis, as muscle strength can be affected by various other conditions.
C. **Electromyography (EMG):** EMG is a valuable tool to assess neuromuscular transmission and identify abnormalities, such as myopathic changes and repetitive nerve stimulation. However, it does not replace the need for clinical evaluation and AChR antibodies testing.
**Clinical Pearl:** A combination of clinical evaluation, including the Mussel sign (fatigue on repetitive testing of a muscle) and the Osserman's criteria, along with AChR antibodies testing, are essential for diagnosing myasthenia gravis. Electromyography and muscle strength tests are helpful adjuncts but do not replace the other diagnostic methods.
**Correct Answer:** D. AChR antibodies testing is essential for diagnosing myasthenia gravis, as it detects autoantibodies targeting the acetylcholine receptors at the neuromuscular junction. A positive AChR antibody test strongly suggests MG, while a negative result excludes the possibility of MG in most cases. AChR antibodies are specific for myasthenia gravis, whereas other tests focus on the overall neuromuscular function or muscle strength.